These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12195266)

  • 1. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Dis Mon; 2002 May; 48(5):367-83. PubMed ID: 12195266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Semin Cutan Med Surg; 2001 Jun; 20(2):127-36. PubMed ID: 11474745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type B (Myobloc): pharmacology and biochemistry.
    Callaway JE
    Clin Dermatol; 2004; 22(1):23-8. PubMed ID: 15158541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions.
    Aoki KR; Guyer B
    Eur J Neurol; 2001 Nov; 8 Suppl 5():21-9. PubMed ID: 11851731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xeomin: an innovative new botulinum toxin type A.
    Frevert J
    Eur J Neurol; 2009 Dec; 16 Suppl 2():11-3. PubMed ID: 20002741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemistry of botulinum toxin type B.
    Setler P
    Neurology; 2000; 55(12 Suppl 5):S22-8. PubMed ID: 11188981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion, spread, and migration of botulinum toxin.
    Ramirez-Castaneda J; Jankovic J; Comella C; Dashtipour K; Fernandez HH; Mari Z
    Mov Disord; 2013 Nov; 28(13):1775-83. PubMed ID: 23868503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A re-evaluation of the mechanism of action of botulinum toxin on facial movement disorders in man.
    Leon-S FE; Arimura K; Chavez AM
    Med Hypotheses; 1998 Oct; 51(4):305-7. PubMed ID: 9824836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of botulinum neurotoxin serotype A.
    Wenzel RG
    Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S5-10. PubMed ID: 15598004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin as a therapeutic agent.
    Tsui JK
    Pharmacol Ther; 1996; 72(1):13-24. PubMed ID: 8981568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current clinical applications of botulinum toxin.
    Truong DD; Stenner A; Reichel G
    Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
    Coffield JA; Bakry N; Zhang RD; Carlson J; Gomella LG; Simpson LL
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties and use of botulinum toxin and other microbial neurotoxins in medicine.
    Schantz EJ; Johnson EA
    Microbiol Rev; 1992 Mar; 56(1):80-99. PubMed ID: 1579114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment outcome with different formulations of botulinum toxin.
    Pérez-Saldaña MT; Tan EK; Burguera JA
    Eur J Neurol; 2009 Mar; 16(3):285-6. PubMed ID: 19364359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
    Coffield JA; Bakry NM; Maksymowych AB; Simpson LL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats.
    Gui D; De Gaetano A; Spada PL; Viggiano A; Cassetta E; Albanese A
    Aliment Pharmacol Ther; 2000 Jun; 14(6):829-34. PubMed ID: 10848669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from botulinum neurotoxin poisoning in vivo.
    Keller JE
    Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.